Background IL-10 exhibits anti-inflammatory effects on activated rodent mas
t cells (MC) in vitro and inhibits allergen-induced airway inflammation in
vivo in murine models. The effects of IL-10 on the allergic activation of h
uman MC are presently unknown.
Objective In light of the well-known heterogeneity of mast cell reactivity
between animal species, one cannot readily predict the response of human MC
to IL-10. Moreover, the impact of IL-10 on MC-derived proinflammatory medi
ators is still unknown. Thus, the objective of this study was to investigat
e the effects of IL-IO on the release of inflammatory mediators by IgE/anti
-IgE-challenged human cord blood-derived mast cells (CBMC), used as an in v
itro model of MC phenotypically similar to human lung MC.
Materials and methods Highly purified human MC were obtained by a first ste
p of longterm culture of cord blood mononuclear cells in the presence of hu
man recombinant stem cell factor (rhSCF) and of human recombinant IL-6 (rhI
L-6), followed by a second step of purification by depletion of contaminati
ng cells with an immunomagnetic method. The cells were treated with human I
gE, then challenged with anti-human IgE, in the presence or the absence of
recombinant rhIL-10 used at various concentrations. Histamine, tumour necro
sis factor-alpha (TNF-alpha), IL-5 and IL-8 were measured in the various su
pernatants collected at different times after the beginning of the challeng
e.
Results IL-10 inhibited the release of TNF-alpha and of IL-8, but not of IL
-5, by activated CBMC. Interestingly, IL-10 also inhibited the release of h
istamine by activated CBMC, contrasting with data reported for rodent MC.
Conclusions These findings suggest that IL-10 might have anti-inflammatory
effects on IgE/anti-IgE-challenged human MC by inhibiting their release of
TNF-alpha, IL-8 and histamine. These data provide new insights into the con
trol of human mast cell activation and might lead to a better knowledge of
the cellular mechanisms controlling allergic reactions.